BRWA
DERM icon

B. Riley Wealth Advisors’s Journey Medical DERM Stock Holding History

B. Riley Wealth Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,250
Closed -$27.4K – 1549
2023
Q2 		$27.4K Hold
17,250
– – ﹤0.01% 1507
2023
Q1 		$27.1K Hold
17,250
– – ﹤0.01% 1463
2022
Q4 		$33.1K Hold
17,250
– – ﹤0.01% 1430
2022
Q3 		$43K Buy
+17,250
New +$58.8K ﹤0.01% 1389

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

B. Riley Wealth Advisors's DERM Position: Q3 2023 in Review

B. Riley Wealth Advisors sold out of Journey Medical (DERM) in Q3 2023, closing a stake of 17,250 shares — an estimated $27.4K sold.

B. Riley Wealth Advisors first reported a position in DERM in Q3 2022 and held it in 4 quarters. The position peaked at $43K in Q3 2022. 21 funds tracked by Wall St. Rank hold DERM as of Q3 2023.

  • B. Riley Wealth Advisors reported no remaining Journey Medical position as of Q3 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 17,250 Journey Medical shares in Q3 2023, an estimated $27.4K.
  • B. Riley Wealth Advisors first reported a position in Journey Medical in Q3 2022 and held it in 4 quarters.
  • B. Riley Wealth Advisors's Journey Medical position peaked at $43K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Journey Medical as of Q3 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2023, filed 1 Dec 2023.